The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Baranich A.I.

Burdenko Neurosurgery Institute, 4-ya Tverskaya-Yamskaya Str., 16, Moscow, Russia, 125047

Savin I.A.

Federal State Autonomous Institution «N.N. Burdenko National Medical Research Center for Neurosurgery» of the Ministry of Healthcare of the Russian Federation, Moscow, Russia, 125047, Moscow, 4-th Tverskaya-Yamskaya str.,16, Russia

Tabasaranskiĭ T.F.

FGBU "NII neĭrokhirurgii im. N.N. Burdenko" RAMN, Moskva

Polupan A.A.

NII neĭrokhirurgii im. akad. N.N. Burdenko RAMN, Moskva

Sychev A.A.

FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

Kurdyumova N.V.

Federal State Autonomous Institution «N.N. Burdenko National Medical Research Center for Neurosurgery» of the Ministry of Healthcare of the Russian Federation, Moscow, Russia, 125047, Moscow, 4-th Tverskaya-Yamskaya str.,16, Russia

Pilipenko Iu.V.

FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

Mikeladze K.G.

Burdenko’ National medical research center of neurosurgery, Moscow, Russia

Éliava Sh.Sh.

NII neĭrokhirurgii im. akad. N.N. Burdenko RAMN, Moskva

Disturbances of the hemostatic system in patients with aneurysmal subarachnoid hemorrhage

Authors:

Baranich A.I., Savin I.A., Tabasaranskiĭ T.F., Polupan A.A., Sychev A.A., Kurdyumova N.V., Pilipenko Iu.V., Mikeladze K.G., Éliava Sh.Sh.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2018;82(4): 109‑116

Read: 1049 times


To cite this article:

Baranich AI, Savin IA, Tabasaranskiĭ TF, et al. . Disturbances of the hemostatic system in patients with aneurysmal subarachnoid hemorrhage. Burdenko's Journal of Neurosurgery. 2018;82(4):109‑116. (In Russ., In Engl.)

Recommended articles:

References:

  1. Konovalov AN, Filatov YuM, Tissen TP, Eliava ShSh, Yakovlev SB, Pronin IN, Usachev DYu. Surgical treatment of cerebral vascular diseases. Zh Nevrologii I Psihiatrii im. S.S. Korsakova. 2015;115(7):4-21. (In Russ.) https://doi.org/10.17116/jnevro2015115714-21
  2. Konovalov AN, Krylov VV, Filatov YuM, Eliava ShSh, Belousova OB. The recommended protocol for managing patients with subarachnoid hemorrhage due to rupture of cerebral aneurysms. Zh Vopr Neirokhir im N.N. Burdenko. 2006;3:3-11. (In Russ.)
  3. Zlokovic BV. Antithrombotic, procoagulant, and fibrinolytic mechanisms in cerebral circulation: implications for brain injury and protection. Neurosurg Focus. 1997 Jun 15;2(6):e5. https://doi.org/10.3171/foc.1997.2.6.8
  4. Rosenberg RD, Aird WC. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med. 1999 May 20;340(20):1555-1564. https://doi.org/10.1056/NEJM199905203402007
  5. Liu S, Agalliu D, Yu C, Fisher M. The role of pericytes in blood-brain barrier function and stroke. Curr Pharm Des. 2012;18(25):3653-3662. https://doi.org/10.2174/138161212802002706
  6. Fisher M. Brain regulation of thrombosis and hemostasis: from theory to practice. Stroke. 2013 November;44(11):3275-3285. https://doi.org/10.1161/STROKEAHA.113.000736
  7. Al Ahmad A, Taboada CB, Gassmann M, Ogunshola OO. Astrocytes and pericytes differentially modulate blood-brain barrier characteristics during development and hypoxic insult. J Cereb Blood Flow Metab. 2011 Feb;31(2): 693-705. https://doi.org/10.1038/jcbfm.2010.148
  8. Bouchard BA, Shatos MA, Tracy PB. Human brain pericytes differentially regulate expression of procoagulant enzyme complexes comprising the extrinsic pathway of blood coagulation. Arterioscler Thromb Vasc Biol. 1997 Jan;17(1):1-9. https://doi.org/10.1161/01.atv.17.1.1
  9. Berlot G. Hemocoagulative problems in the critically ill patient. Springer. 2012;227-236. https://doi.org/10.1007/978-88-470-2448-9_8
  10. Monroe DM, Hoffman M. Theories of blood coagulation: basic concepts and recent updates. Hemostasis and Thrombosis. 2014. https://doi.org/10.1002/9781118833391.ch1
  11. Lichtin A, Bartholomew J. The coagulation consult. A case-based guide. Springer. 2014;4-6. https://doi.org/10.1007/978-1-4614-9560-4
  12. Mackman N. The role of tissue factor and factor VIIa in hemostasis. Anesth Analg. 2009 May;108(5):1447-1452. https://doi.org/10.1213/ane.0b013e31819bceb1
  13. Harhangi BS, Kompanje EJ, Leebeek FW. Coagulation disorders after traumatic brain injury. Acta Neurochir (Wien). 2008 Feb;150(2):165-175; discussion 175. https://doi.org/10.1007/s00701-007-1475-8
  14. Pathak A, Dutta S, Marwaha N, Singh D, Varma N. Change in tissue thromboplastin content of brain following trauma. Neurol India. 2005 Jun;53(2): 178-182. https://doi.org/10.4103/0028-3886.16404
  15. Gerlach R, Krause M, Seifert V. Hemostatic and hemorrhagic problems in neurosurgical patients. Acta Neurochir (Wien). 2009 Aug;151(8):873-900; discussion 900. https://doi.org/10.1007/s00701-009-0409-z
  16. Rowland MJ, Hadjipavlou G, Kelly M, Westbrook J, Pattinson KT. Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm. Br J Anaesth. 2012 Sep;109(3):315-329. https://doi.org/10.1093/bja/aes264
  17. Budohoski KP, Guilfoyle M, Helmy A, Huuskonen T, Czosnyka M. The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2014 Dec;85(12): 1343-1353. https://doi.org/10.1136/jnnp-2014-307711
  18. Sehba FA, Mostafa G, Friedrich VJr, Bederson JB. Acute microvascular platelet aggregation after subarachnoid hemorrhage. J Neurosurg. 2005 Jun; 102(6):1094-1100. https://doi.org/10.3171/jns.2005.102.6.1094
  19. Stein SC, Browne KD, Chen XH, Smith DH, Graham DI. Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study. Neurosurgery. 2006 Oct;59(4):781-787;discussion 787-788. https://doi.org/10.1227/01.NEU.0000227519.27569.45
  20. Juvela S, Hillbom M, Kaste M. Platelet thromboxane release and delayed cerebral ischemia in patients with subarachnoid hemorrhage. Journal of Neurosurgery March. 1991;74(3):386-392. https://doi.org/10.3171/jns.1991.74.3.0386
  21. Hirashima Y, Endo S, Ohmori T, Kato R, Takaku A. Platelet-activating factor (PAF) concentration and PAF acetylhydrolase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage. J Neurosurg. 1994 Jan; 80(1):31-36. https://doi.org/10.3171/jns.1994.80.1.0031
  22. Frontera JA, Provencio JJ, Sehba FA, McIntyre TM, Nowacki AS, Gordon E, Weimer JM, et al. The role of platelet activation and inflammation in early brain injury following subarachnoid hemorrhage. Neurocrit Care. 2017 Feb;26(1):48-57. https://doi.org/10.1007/s12028-016-0292-4
  23. Thomas ME, Osmani AH, Scrutton MC. Some properties of the human platelet vasopressin receptor. Thromb Res. 1983 Dec 15;32(6):557-566. https://doi.org/10.1016/0049-3848(83)90057-9
  24. Friedrich B, Müller F, Feiler S, Schöller K, Plesnila N. Experimental subarachnoid hemorrhage causes early and long-lasting microarterial constriction and microthrombosis: an in vivo microscopy study. J Cereb Blood Flow Metab. 2012 Mar;32(3):447-455. https://doi.org/10.1038/jcbfm.2011.154
  25. Liu ZW, Gu H, Zhang BF, Zhao YH, Zhao JJ, Zhao YL, Ma XD, Song JN. Rapidly increased vasopressin promotes acute platelet aggregation and early brain injury after experimental subarachnoid hemorrhage in a rat model. Brain Res. 2016 May 15;1639:108-119. https://doi.org/10.1016/j.brainres.2016.02.038
  26. Hockel K, Schöller K, Trabold R, Nussberger J. Vasopressin V(1a) receptors mediate posthemorrhagic systemic hypertension thereby determining rebleeding rate and outcome after experimental subarachnoid hemorrhage. Stroke. 2012 Jan;43(1):227-232. https://doi.org/10.1161/STROKEAHA.111.626168
  27. Foreman PM, Chua M, Harrigan MR, Fisher WS3rd, Vyas NA, Lipsky RH, Walters BC, Tubbs RS, Shoja MM. Association of nosocomial infections with delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. J Neurosurg. 2016 Dec;125(6):1383-1389. https://doi.org/10.3171/2015.10.JNS151959
  28. Levi M, van der Poll T, Büller HR. Bidirectional relation between inflammation and coagulation. Circulation. 2004 Jun 8;109(22):2698-2704. https://doi.org/10.1161/01.CIR.0000131660.51520.9A
  29. Hendryk S, Jarzab B, Josko J. Increase of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAH. Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):141-147.
  30. McMahon CJ, Hopkins S, Vail A, King AT, Smith D, Illingworth KJ, Clark S., Rothwell NJ. Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage. J Neurointerv Surg. 2013 Nov; 5(6):512-517. https://doi.org/10.1136/neurintsurg-2012-010386
  31. Hamilton MG, Golfios JG, Pineo GF. Handbook of bleeding and coagulation for Neurosurgery. Thieme. 2015;17-24. https://doi.org/10.1055/b-003-120845
  32. Grote E, Hassler W. The critical first minutes after subarachnoid hemorrhage. Neurosurgery. 1988 Apr;22(4):654-661. https://doi.org/10.1097/00006123-198804000-00006
  33. Sehba FA, Bederson JB. Mechanisms of acute brain injury after subarachnoid hemorrhage. Neurol Res. 2006 Jun;28(4):381-398. https://doi.org/10.1179/016164106X114991
  34. Friedrich V, Flores R, Muller A, Bi W, Peerschke EI, Sehba FA. Reduction of neutrophil activity decreases early microvascular injury after subarachnoid haemorrhage. J Neuroinflamm. 2011;8:103. https://doi.org/10.1186/1742-2094-8-103
  35. Sehba FA, Friedrich V. Early micro vascular changes after subarachnoid hemorrhage. Acta Neurochir Suppl. 2011;110(1):49-55. https://doi.org/10.1007/978-3-7091-0353-1_9
  36. Smyth SS, McEver RP, Weyrich AS, Morrell CN, Hoffman MR. Platelet functions beyond hemostasis. J Thromb Haemost. 2009 Nov;7(11):1759-1766. https://doi.org/10.1111/j.1538-7836.2009.03586.x
  37. Friedrich V, Flores R, Muller A, Sehba FA. Luminal platelet aggregates in functional deficits in parenchymal vessels after subarachnoid hemorrhage. Brain Res. 2010 Oct 1;1354:179-187. https://doi.org/10.1016/j.brainres.2010.07.040
  38. Friedrich V, Flores R, Muller A, Sehba FA. Escape of intraluminal platelets into brain parenchyma after subarachnoid hemorrhage. Neuroscience. 2010 Feb 3;165(3):968-975. https://doi.org/10.1016/j.neuroscience.2009.10.038
  39. Dorhout Mees SM, Rinkel GJ, Hop JW, Algra A, van Gijn J. Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: a systematic review. Stroke. 2003 Sep;34(9):2285-2289. https://doi.org/10.1161/01.STR.0000083621.44269.3E
  40. Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J. AHA/ASA guideline guidelines for the management of aneurysmal subarachnoid hemorrhage Stroke. 2012;43:1711-1737. https://doi.org/10.1161/STR.0b013e3182587839
  41. Siironen J, Juvela S, Varis J, Porras M, Poussa K, Ilveskero S, Hernesniemi J. No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial. J Neurosurg. 2003 Dec;99(6):953-959. https://doi.org/10.3171/jns.2003.99.6.0953
  42. Roos YB, Rinkel GJ, Vermeulen M, Algra A. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2003;(2): CD001245. https://doi.org/10.1002/14651858.CD001245

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.